Tumor lysis syndrome(TLS) is a frequent clinical syndrome nephrologists encounter.
The Cairo Bishop classification allows for the diagnosis of TLS
1. Uric acid >= 8.0
2. K >= 6.0
3. Phos >= 4.6
4. Calcium <7.0
6. Cardiac arrhythmia
7. Seizure or symptomatic hypocalcemia
Two of the four lab criteria have to be met within 24 hours period and 3 days before to 7 days after receiving chemotherapy and no other cause of AKI has to be found. Interestingly, LDH is not a criteria to help diagnose TLS but is usually the most useful clinically. If one looks at risk factors, LDH is included along with WBC count, tumor burden, renal function at baseline and baseline uric acid levels.
- ► 2018 (27)
- ► 2017 (52)
- ► 2016 (45)
- ► 2015 (63)
- ► 2014 (95)
- ► 2013 (133)
- SPECIAL: Resident's view on Nephrology
- Rise of Interventional Nephrology
- In the News: Sub group analyses in Nephrology tria...
- Obesity and ESRD
- CONSULT ROUNDS: Tumor lysis syndrome 2
- Topic Discussion: Vitamin D receptor and Renin ang...
- A resident's view
- CLINICAL CASE 60 Answers and Summary
- NEJM Blog: Stroke and Bleeding in Afib with CKD
- The rise of Onco-Nephrology
- CONSULT ROUNDS: Tumor Lysis Syndrome 1
- CONSULT ROUNDS: Minimal Change and Lupus?
- CONSULT ROUNDS: Hematuria and renal failure?
- Topic Discussion: Iron during infections?
- Topic Discussion: ENCAPSULATING PERITONEAL SCLEROS...
- Invited commentary: Nephrology and ACA decision
- Topic Discussion: Rule of 6s
- Nephrology Crosswords: Divalents
- ▼ August (18)
- ► 2011 (370)
- ► 2010 (461)